… anti-inflammatory and anti-fibrotic agent against BLM-induced pulmonary fibrosis in rats. …
target for therapeutic intervention of pulmonary fibrosis. Fibrosis associated with BLM treatment …

… of the fibrosis. This study investigated the role of resveratrol on the treatment of bleomycin-induced
pulmonary fibrosis. Intratracheal bleomycin (2.5 mg/kg) was given in fibrosis groups …

… of the lungs from these rats, we suggest that this exposure regimen gives rise to a new animal
model of progressive pulmonary fibrosis with many potential benefits over existing models. …

… Pulmonary fibrosis as the end result of a multitude of … of pulmonary fibrosis (1-5). We have
previously reported the development of a rat model of bleomycin-induced pulmonary fibrosis (6…

… degree of pulmonary fibrosis. Further … of pulmonary fibrosis rats were also decreased by
losartan. Conclusions: Losartan had an inhibitory effect on bleomycin-induced pulmonary fibrosis…

… of amiodarone-induced lung fibrosis, management of this lung … the development of amiodarone
pulmonary fibrosis are scanty. … attenuates amiodarone-induced pulmonary fibrosis in rats. …

… BLM-induced pulmonary fibrosis, and … pulmonary fibrosis have not been studied. We
therefore examined whether a high level of circulating BIL in rats inhibits the pulmonary fibrosis …

… pulmonary fibrosis was assessed as hydroxyproline content in lung homogenates. Findings
show that BLM‐induced pulmonary … BALF of BLM‐treated rats. Melatonin provided protection …

… in lungs in bleomycin-treated rats (E), and bleomycin-treated rats after treatment with high
… on bleomycin-induced pulmonary fibrosis, we treated diseased rats with various doses of …

… In conclusion, pirfenidone, prednisone and acetylcysteine can inhibit airsacculitis and
pulmonary fibrosis in rat IPF models, and its mechanisms may be related with enhanced caveolin-1…